Measurement of Retinal Auto Fluorescence With a Fluorescence Lifetime Imaging Ophthalmoscope (FLIO-Group)
Sponsor: Insel Gruppe AG, University Hospital Bern
Listed as NCT01981148, this observational or N/A phase trial focuses on Autofluorescence Imaging and Neuroimaging and remains ongoing. Sponsored by Insel Gruppe AG, University Hospital Bern, it has been updated 13 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Jun 2025 — Sep 2025 [monthly]
Unknown
Status: Enrolling By Invitation → Unknown
-
Sep 2024 — Jun 2025 [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
-
Jul 2023 — Jul 2024 [monthly]
Enrolling By Invitation
▶ Show 8 earlier versions
-
Jan 2023 — Jul 2023 [monthly]
Enrolling By Invitation
-
Nov 2021 — Jan 2023 [monthly]
Enrolling By Invitation
-
Jan 2021 — Nov 2021 [monthly]
Enrolling By Invitation
-
Oct 2019 — Jan 2021 [monthly]
Enrolling By Invitation
Status: Unknown Status → Enrolling By Invitation
-
Mar 2019 — Oct 2019 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Enrolling By Invitation
-
Apr 2018 — Jun 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
First recorded
Feb 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Insel Gruppe AG, University Hospital Bern
For direct contact, visit the study record on ClinicalTrials.gov .